Ftse Mib
33.445,44
-0,15%
DAX
19.405,20
0,51%
S&P 500
5.983,80
0,24%
NASDAQ
19.041,52
0,20%
Bitcoin
95.818,73
-2,28%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada NEO Halo Collective Inc (HALO) Halo Collective Inc (HALO) Notizie

Halo Collective Inc

HALO
0,02
0,00 (0,00%)
01:00:00 - Dati in Tempo Reale
Borsa: NEO
Tipo: Azione
Valuta: CAD

Ultime notizie

Data Ora Fonte Titolo
22/11/202414:35PRNUSHalozyme Withdraws Proposal to Acquire Evotec Following..
14/11/202422:15PRNUSHalozyme Confirms Proposal to Combine with Evotec for €11.00..
12/11/202415:36EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
31/10/202421:05EDGAR2Form 8-K - Current report
31/10/202421:01PRNUSHALOZYME REPORTS THIRD QUARTER 2024 FINANCIAL AND OPERATING..
24/10/202412:30PRNUSHALOZYME PROVIDES UPDATE ON LICENSEE CO-FORMULATION PATENT..
23/10/202422:30PRNUSHalozyme to Report Third Quarter 2024 Financial and..
17/10/202400:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202422:14EDGAR2Form 144 - Report of proposed sale of securities
15/10/202422:34EDGAR2Form 144 - Report of proposed sale of securities
10/10/202414:09IHNWZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for..
09/10/202423:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/10/202422:09EDGAR2Form 144 - Report of proposed sale of securities
08/10/202422:08EDGAR2Form 144 - Report of proposed sale of securities
03/10/202414:00PRNUSHalozyme Announces Expansion of Global Collaboration and..
27/9/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202422:05EDGAR2Form 144 - Report of proposed sale of securities
25/9/202422:00EDGAR2Form 144 - Report of proposed sale of securities
24/9/202422:05EDGAR2Form 144 - Report of proposed sale of securities
19/9/202400:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202422:01EDGAR2Form 144 - Report of proposed sale of securities
17/9/202422:03EDGAR2Form 144 - Report of proposed sale of securities
13/9/202419:30PRNUSHalozyme Announces FDA Approval of Roche's Subcutaneous..
13/9/202402:00PRNUSHalozyme Announces FDA Approval of Roche's Tecentriq..
12/9/202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202422:12EDGAR2Form 144 - Report of proposed sale of securities
11/9/202422:05EDGAR2Form 144 - Report of proposed sale of securities
10/9/202422:16EDGAR2Form 144 - Report of proposed sale of securities
28/8/202414:30PRNUSHalozyme to Present at Upcoming Investor Conferences
28/8/202401:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202400:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202422:11EDGAR2Form 144 - Report of proposed sale of securities
20/8/202422:16EDGAR2Form 144 - Report of proposed sale of securities
15/8/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202422:31EDGAR2Form 144 - Report of proposed sale of securities
14/8/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202422:08EDGAR2Form 144 - Report of proposed sale of securities
13/8/202422:19EDGAR2Form 144 - Report of proposed sale of securities
06/8/202422:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202422:03EDGAR2Form 8-K - Current report
06/8/202422:01PRNUSHALOZYME REPORTS SECOND QUARTER 2024 FINANCIAL AND OPERATING..
24/7/202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202422:05EDGAR2Form 144 - Report of proposed sale of securities
23/7/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/7/202422:11EDGAR2Form 144 - Report of proposed sale of securities
23/7/202414:30PRNUSHalozyme to Report Second Quarter 2024 Financial and..
22/7/202422:13EDGAR2Form 144 - Report of proposed sale of securities
25/6/202407:15PRNUSHalozyme Announces Roche's OCREVUS® SC with ENHANZE®..
21/6/202423:15PRNUSHalozyme Announces argenx Receives FDA Approval for VYVGART®..
18/6/202422:22EDGAR2Form 144 - Report of proposed sale of securities
Apertura: Min: Max:
Chiusura: 0,02

La tua Cronologia

NEO
HALO
Halo Collective
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network